The Senior Medical Science Liaison will cultivate scientific relationships with KOLs and support clinical trial recruitment for the Duchenne Muscular Dystrophy program. They will also gather scientific insights, provide clinical expertise for communications, and represent the company at medical conferences.
Develop and execute regional commercial strategies, lead account and stakeholder engagement, and prepare treatment centers for product launches and patient access. Coordinate cross-functional teams, address operational and reimbursement barriers, build referral partnerships, and track launch performance and market trends.
The Market Development Director will drive regional strategy and commercial launch readiness for gene therapies in rare and neuromuscular diseases. They will lead strategic engagement with key stakeholders and treatment centers to ensure alignment with corporate go-to-market objectives.
Develop and execute regional account strategies, lead launch planning, and build relationships with treatment centers, thought leaders, and other stakeholders to support access and adoption of REGENXBIO therapies. Assess treatment center readiness and barriers to care, coordinate cross-functional resources, track launch KPIs, and monitor regional market, payer, and regulatory trends.
The Senior Director, Payer Accounts will lead strategic engagement with national and regional payers, PBMs, and GPOs to ensure patient access to gene therapies. They are responsible for developing and executing market access strategies, negotiating contracts, and building long-term relationships with key payer stakeholders.
The VP will lead the overall strategy, commercialization, and P&L performance of the rare disease franchise, including the launch of RGX-202. They will partner with executive leadership to drive cross-functional alignment and represent the rare disease community in company-wide growth strategies.
The Head of Sales will oversee the commercial field strategy, execution, and revenue growth for the company's rare disease portfolio. This role involves leading and developing high-performing field teams while partnering with cross-functional departments to ensure successful product launches and patient access.
The Associate Director will lead global regulatory strategy for therapeutic areas from early development through marketing authorization. They will manage critical submission activities, partner cross-functionally, and represent the company in interactions with global health authorities.
The Director will build and lead data, advanced analytics, and forecasting capabilities to support commercial decision-making and launch readiness. They are responsible for designing measurement frameworks, managing complex commercial datasets, and translating analytical findings into actionable recommendations for senior leadership.
